Positives: First patient dosed in Phase II tr
Post# of 154472

Positives:
First patient dosed in Phase II trial for colorectal cancer treatment
Partnership with Syneos Health and engagement of eight clinical sites
Building on previous promising research in CRC and breast cancer
Targeting large market opportunity with 1.9 million new CRC cases annually
https://www.stocktitan.net/news/CYDY/cyto-dyn...cv6mw.html

